Renovaro Inc.

NASDAQ:RENB 1:00:00 PM EDT

0.29

+0.01 (+3.44%)

4:40:07 PM EDT: $0.29 0.00 (-0.66%)

Renovaro Inc. Stock, NASDAQ:RENB

2080 Century Park East, Suite 906, Los Angeles, California 90067

United States of America

Phone: +1.305.918.1980

Number of Employees: 25

http://renovarobio.com

Description

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.